These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8309679)

  • 1. Aldose reductase inhibition and the phosphorus-31 profile of the intact diabetic rat lens.
    Tsubota K; Yoshida M; Toda T; Ono M; Kajiwara K; Cheng HM
    Ophthalmic Res; 1993; 25(6):393-9. PubMed ID: 8309679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The utilization of 13C and 31P nuclear magnetic resonance spectroscopy in the study of the sorbitol pathway and aldose reductase inhibition in intact rabbit lenses.
    Williams WF; Odom JD
    Exp Eye Res; 1987 Jun; 44(6):717-30. PubMed ID: 3115803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of insulin and aldose reductase inhibition on the phosphate metabolism of streptozotocin-diabetic rat lens.
    Cheng HM; Yoshida A; Xiong H; González RG
    Exp Eye Res; 1991 Dec; 53(6):805-8. PubMed ID: 1783017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of an aldose reductase inhibitor on lens phosphorylcholine under hyperglycemic conditions: biochemical and NMR studies.
    Lou MF; Garadi R; Thomas DM; Mahendroo PP; York BM; Jernigan HM
    Exp Eye Res; 1989 Jan; 48(1):11-24. PubMed ID: 2493385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metabolic changes of aldose and phosphorus metabolites in incubated rabbit lenses--effects of aldose reductase inhibitor].
    Nakamura J; Itoh S; Kani K; Okamoto R
    Nippon Ganka Gakkai Zasshi; 1998 Sep; 102(9):561-9. PubMed ID: 9785852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 31P NMR studies of the diabetic lens.
    González RG; Miglior S; Von Saltza I; Buckley L; Neuringer LJ; Cheng HM
    Magn Reson Med; 1988 Apr; 6(4):435-44. PubMed ID: 3132582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered phosphate metabolism in the intact rabbit lens under high glucose conditions and its prevention by an aldose reductase inhibitor.
    González RG; Barnett P; Cheng HM; Chylack LT
    Exp Eye Res; 1984 Nov; 39(5):553-62. PubMed ID: 6440802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GP-1447, an inhibitor of aldose reductase, prevents the progression of diabetic cataract in rats.
    Kawakubo K; Mori A; Sakamoto K; Nakahara T; Ishii K
    Biol Pharm Bull; 2012; 35(6):866-72. PubMed ID: 22687477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of instillation of aldose reductase inhibitor FR74366 on diabetic cataract.
    Ao S; Kikuchi C; Ono T; Notsu Y
    Invest Ophthalmol Vis Sci; 1991 Nov; 32(12):3078-83. PubMed ID: 1834606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of an aldose reductase inhibitor on lens metabolism, ATPases and antioxidative defense in streptozotocin-diabetic rats: an intervention study.
    Obrosova IG; Fathallah L
    Diabetologia; 2000 Aug; 43(8):1048-55. PubMed ID: 10990083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organophosphate metabolic changes in the rat lens during the development of galactose-induced cataract.
    Sakagami K; Igarashi H; Tanaka K; Yoshida A
    Hokkaido Igaku Zasshi; 1999 Nov; 74(6):457-66. PubMed ID: 10642892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dietary taurine supplementation on GSH and NAD(P)-redox status, lipid peroxidation, and energy metabolism in diabetic precataractous lens.
    Obrosova IG; Stevens MJ
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):680-8. PubMed ID: 10067971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonosmotic diabetic cataracts.
    Malone JI; Lowitt S; Cook WR
    Pediatr Res; 1990 Mar; 27(3):293-6. PubMed ID: 2138728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of vanadate on glucose metabolism of the streptozotocin-diabetic rat lens].
    Endo M
    Nippon Ganka Gakkai Zasshi; 1993 Mar; 97(3):333-9. PubMed ID: 8317350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The further metabolism of sorbitol-3-phosphate and fructose-3-phosphate in the mature rat lens.
    Cheng HM; Cheng FY; Xiong H; Xiong J
    Ophthalmic Res; 1996; 28(1):57-63. PubMed ID: 8726678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyol pathway activity in streptozotocin-diabetic rat lens.
    Cheng HM; Hirose K; Xiong H; González RG
    Exp Eye Res; 1989 Jul; 49(1):87-92. PubMed ID: 2759193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of Zopolrestat and Sorbinil on lens myo-inositol influx.
    Beyer-Mears A; Diecke FP; Mistry K; Cruz E
    Pharmacology; 1997 Feb; 54(2):76-83. PubMed ID: 9088040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of D-sorbitol 3-phosphate in the normal and diabetic mammalian lens.
    Szwergold BS; Kappler F; Brown TR; Pfeffer P; Osman SF
    J Biol Chem; 1989 Jun; 264(16):9278-82. PubMed ID: 2722832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic phosphorus-31 NMR study of sugar cataract and its prevention in rat lenses with aldose reductase inhibitors.
    Thomas DM; Mahendroo PP; Lou MF
    Exp Eye Res; 1988 Jan; 46(1):37-47. PubMed ID: 3125056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fructose-3-phosphate production and polyol pathway metabolism in diabetic rat hearts.
    Lal S; Randall WC; Taylor AH; Kappler F; Walker M; Brown TR; Szwergold BS
    Metabolism; 1997 Nov; 46(11):1333-8. PubMed ID: 9361695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.